Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus remazolam versus fentanyl plus remazolam for sedation in elderly patients undergoing fibrobronchoscopy
ChiCTR2400084672Phase 4Recruiting
- Sponsor
- Deyang People's Hospital
- Start
- Aug 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esketamine, remimazolam mesylate and fentanyl (2 arms), sponsored by Deyang People's Hospital. Primary endpoint: Incidence of respiratory depression. Started Aug 2023; status: recruiting.
02
Drugs
esketamineremimazolam mesylatefentanyl
Beyond the preview
Go deeper on ChiCTR2400084672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084672.